PD 184352 (CI-1040) (DMSO solution), MEK1/2 inhibitor

Alternative names

AA589381, ACLS, AI838772, AIE 2, AIK 3, AIS, ANDR_HUMAN, AR, AR8, ARK-3, AURKC_HUMAN, AW493413, Aie1, Alpha CaMKII, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Antigen NY-CO-13, Aur C, Aurora C, Aurora kinase C, Aurora-related kinase 3, Aurora/Ipl1-related kinase 3, Aurora/Ipl1/Eg2 protein 2, BB 2, BCC7, Bombesin BB2 receptor, CA 1, CA 12, CA 2, CA-I, CA-II, CA-IX, CA-XII, CA9, CAB, CAC, CAH12_HUMAN, CAH1_HUMAN, CAH2_HUMAN, CAH9_HUMAN, CAMK II, CAMKA, CAR, CAR BETA, CARA, CATD_HUMAN, CD, CD 140B, CD140A, CD140a antigen, CD140b antigen, CFC3, CK II, CK II alpha, CK II alpha', CK II beta, CK2 alpha, CK2 catalytic subunit alpha, CK2A1, CK2A2, CK2B, CK2N, CLN10, CPSD, CSK21_HUMAN, CSK22_HUMAN, CSK2B_HUMAN, CSNK 2B, CTSD, CaM kinase II alpha chain, CaM kinase II alpha subunit, CaM kinase II subunit alpha, CaMK II alpha subunit, CaMK-II subunit alpha, CaMKIINalpha, Calcium calmodulin dependent protein kinase II, Calcium/calmodulin dependent protein kinase II alpha B subunit, Calcium/calmodulin dependent protein kinase type II alpha chain, Calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha, Calcium/calmodulin-dependent protein kinase II-alpha, Calcium/calmodulin-dependent protein kinase type II subunit alpha, Calcium/calmodulin-dependent protein kinase type IIA, Camk2a, Car 1, Car 2, Carbonate dehydratase I, Carbonate dehydratase II, Carbonate dehydratase IX, Carbonate dehydratase XII, Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 2, Carbonic anhydrase 9, Carbonic anhydrase A, Carbonic anhydrase B, Carbonic anhydrase B, formerly, Carbonic anhydrase C, Carbonic anhydrase C, formerly, Carbonic anhydrase I, Carbonic anhydrase II, Carbonic anhydrase IX, Carbonic anhydrase XII, Carbonic dehydratase, Casein kinase 2 alpha, Casein kinase 2 alpha 1 polypeptide, Casein kinase 2 alpha prime polypeptide, Casein kinase 2 beta polypeptide, Casein kinase II alpha 1, Casein kinase II alpha 1 subunit, Casein kinase II alpha subunit, Casein kinase II alpha' chain, Casein kinase II beta subunit, Casein kinase II subunit alpha, Casein kinase II subunit alpha', Casein kinase II subunit beta, Cathepsin D, Cathepsin D heavy chain, Cellular tumor antigen p53, Ceroid lipofuscinosis neuronal 10, Constitutive activator of retinoid response, Constitutive active response, Constitutive androstane receptor, Craf 1 transforming gene, DHTR, DNA binding protein, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2, EC 2.7.11.1, EC 2.7.11.17, EC 2.7.12.2, ECK0125, ERK activator kinase 1, ERK activator kinase 2, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ESRL 1, ESRR A, Epididymis secretory protein Li 282, Epididymis secretory sperm binding protein Li 130P, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen-related receptor alpha, Estrra, FLJ11090, FLJ20151, FLJ26075, FLJ43934, FLJ92943, G protein coupled receptor 142, G-protein coupled receptor PGR2, G5A, GCCR, GCPS, GCRST, GCR_HUMAN, GLI Kruppel family member GLI 3, GLI Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome), GLI family zinc finger 3, GLI3 C-terminally truncated form, GLI3 form of 190 kDa, GLI3 form of 83 kDa, GLI3 full length protein, GLI3-190, GLI3-83, GLI3FL, GLI3_HUMAN, GP142_HUMAN, GPR142, GPRC1A, GR, GRM1-Alpha, GRM1A, GRM1_HUMAN, GRP-preferring bombesin receptor, GRPR_HUMAN, Gamma Secretase Subunit PEN2, Gamma-secretase subunit PEN-2, Gastrin-releasing peptide receptor, Glioma associated oncogene family zinc finger 3, Glucocorticoid receptor, Glutamate receptor metabotropic 1, Grl1, Grp/bombesin receptor, HEL S 130P, HEL-76, HEL-S-282, HUMARA, HYSP1, Hematopoietic stem/progenitor cells protein MDS033, HsT18816, IMD42, JW0122, KCC2A_HUMAN, KD, KIAA0968, Kennedy disease (KD), LFS1, Lysosomal aspartyl peptidase, Lysosomal aspartyl protease, MAP kinase kinase 1, MAP kinase kinase 2, MAP kinase/Erk kinase 1, MAP2K1, MAP2K2, MAPK / ERK kinase 2, MAPK/ERK kinase 1, MAPKK 1, MAPKK 2, MB67, MDS033, MEK 1, MEKK 1, MGC104252, MGC112732, MGC123320, MGC129539, MGC138222, MGC138224, MGC139375, MGC155201, MGC2311, MGC97144, MGLU1, MGLUR1-Alpha, MGLUR1A, MKK 1, MKK 2, MN, MP2K1_HUMAN, MSTP064, Membrane antigen MN, Metabotropic glutamate receptor 1, Mitogen Activated Protein Kinase Kinase 1, Mitogen activated protein kinase kinase 2, Mitogen-activated protein kinase kinase 2, p45, Murine sarcoma 3611 oncogene 1, Mutant tumor protein 53, NR1F3, NR1I3_HUMAN, NR3B1, NR3C3, NR3C4, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 1 group I member 3, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 1, Nuclear receptor subfamily 3 group C member 3, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), Oncogene GLI3, Oncogene RAF1, Orphan nuclear receptor MB67, Orphan nuclear receptor NR1I3, P53_HUMAN, P54/58N, PAP A, PAPB, PDGF Receptor alpha + beta, PDGF-R-alpha, PDGF-R-beta, PDGFR 2, PDGFRA, PDGFRB, PEN2_HUMAN, PGR, PGR2, PK2CDD, PKCCD, PPD IV, PR, PRA, PRB, PRGR_HUMAN, PRKMK 1, PRKMK 2, PSEN2, Phosphoprotein p53, Phosvitin, Platelet derived growth factor receptor alpha, Platelet derived growth factor receptor beta, Presenilin Enhancer 2, Presenilin enhancer 2 homolog, Presenilin enhancer protein 2, Probable G-protein coupled receptor 142, Progesterone receptor, Progestin receptor form A, Progestin receptor form B, Protein G5a, Protein kinase mitogen activated kinase 1 (MAP kinase kinase 1), Protein kinase, mitogen-activated, kinase 2, R74975, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-related orphan receptor C, RCC associated protein G250, RCC-associated antigen G250, RORG_HUMAN, RP24-311F12.2, RZR GAMMA, RZRG, Raf proto oncogene serine threonine protein kinase, Renal cell carcinoma-associated antigen G250, Retinoic acid binding receptor gamma, Retinoid-related orphan receptor-gamma, Rorc, SBMA, SCAN1, SCAR13, SMAX1, SPGF5, STK13, Sarcoma 3611 oncogene, Serine threonine protein kinase 13, Serine/threonine-protein kinase 13, Serine/threonine-protein kinase aurora-C, Seven transmembrane helix receptor, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid hormone receptor ERR1, T18816, TFM, TOR, TRP53, TYDP, TYDP1_HUMAN, Testicular Feminization (TFM), Tp53, Transcriptional activator GLI3, Transcriptional repressor GLI3R, Transformation related protein 53, Tumor antigen HOM-RCC-3.1.3, Tumor protein 53, Tumor protein p53, Tumor suppressor p53, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, Zinc finger protein GLI 3, androgen receptor splice variant 4b, aurora 3, bombesin receptor 2, constitutive active receptor, constitutive androstane nuclear receptor variant 2, constitutive androstane nuclear receptor variant 3, constitutive androstane nuclear receptor variant 4, constitutive androstane nuclear receptor variant 5, epididymis luminal protein 76, estrogen receptor related receptor alpha, glucocorticoid nuclear receptor variant 1, hERR1, mGluR1, mKIAA0968, nr3c1, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), orphan nuclear hormone receptor, p53 tumor suppressor, pMW1, protein kinase mitogen-activated kinase 1, psenen, serine/threonine kinase 13 (aurora/IPL1 like), tumor antigen p55, vRaf1 murine leukemia viral oncogene homologue 1, yadF, zgc:112538, zgc:123320